Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies

Synergistic collaboration to revolutionize age-related therapies worldwide Deal valued at over $300…

HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases

Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology…

GoRocky Is Revolutionizing Healthcare Treatments For Men In The Philippines

At GoRocky, men will get access to effective medication, addressing men’s health…

Moomoo's Parent Company Futu Releases Q1 Earnings Result with US$143.3 Million in Non-GAAP Adjusted Net Income, a 18% Increase QoQ

JERSEY CITY, N.J., May 28, 2024 /PRNewswire/ — Moomoo’s parent company Futu…

Alpha X to Make Its Debut at SEMICON SEA 2024 with Cutting-Edge AI-Driven Manufacturing Solutions

SINGAPORE and KUALA LUMPUR, Malaysia, May 28, 2024 /PRNewswire/ — Alpha X,…

A WORLDWIDE SPECTACLE OF FUTURE FASHION TALENTS IS COMING: GLOBAL FASHION COLLECTIVE IS PREPARING FOR THE UPCOMING SS25 SEASON FOR ALL TO GET INVOLVED AND EXPERIENCE FIRST-HAND

"Creating the pathway for future talents." VANCOUVER, British Columbia, May 28, 2024…

OneConnect Announces 2024 Annual General Meeting Results

SHENZHEN, China, May 28, 2024 /PRNewswire/ — OneConnect Financial Technology Co., Ltd.…

Baozun Announces First Quarter 2024 Unaudited Financial Results

SHANGHAI, May 28, 2024 /PRNewswire/ — Baozun Inc. (Nasdaq: BZUN and HKEX:…